ProQR Announces Presentations at ECFS on Eluforsen for F508del Cystic Fibrosis and at CFF Research Conference
(WorldNews Netherlands)

ProQR Announces Presentations at ECFS on Eluforsen for F508del Cystic Fibrosis and at CFF Research Conference LEIDEN, The Netherlands, June 04, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare diseases, today announced upcoming presentations at the European Cystic Fibrosis Society (ECFS) conference and the CFF Research Conference. Presentation at ECFS Conference ProQR will deliver a short talk (ePoster) and a poster presentation on eluforsen during the ECFS: European Cystic Fibrosis Society Conference to be held on June 6 - 9, 2018 in Belgrade,...